News

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...
Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS ...
Option traders moderately bearish in Moderna (MRNA), with shares down $1.45 near $25.68. Options volume relatively light with 55k contracts traded ...
Investing.com -- Moderna Inc (NASDAQ:MRNA) stock fell 5.5% and Pfizer Inc (NYSE:PFE) shares dropped 2.6% following reports from Newsweek and The Daily Beast that the Trump administration may be ...
CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the ...
The Trump administration said it was terminating mRNA vaccine research and shifting focus to other approaches, including a ...
Biotech giant Moderna announced it will lay off 10% of its workforce in a move CEO Stéphane Bancel called “a difficult decision but necessary step forward,” in an internal memo sent to employees on ...
As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...
The approval keeps Moderna on track to deliver doses ahead of the 2025-2026 vaccination season. Production will take place in ...
The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the ...